Company profile
Artiva Biotherapeutics, Inc. Insider Trading
ARTVEvery SEC Form 4 insider trading filing for Artiva Biotherapeutics, Inc. (ARTV) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Biological Products, (No Diagnostic Substances)
- CIK
- 0001817241
- Filings
- 95
- Insiders
- 36
- Last filing
- 2026-09-15
Activity summary
Recent insider activity is bullish. Over the last 30 days, 26 insiders purchased shares versus 4 sales. Buying was led by Fred Aslan.
Three year balance
Buy and sell value by quarter, Q3 24 to Q3 26. Artiva Biotherapeutics, Inc. insiders are net buyers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $165.0M.
90 day insight
Over the last 90 days, Artiva Biotherapeutics, Inc. insiders bought $5.4M (39 transactions) and sold $912K (4 transactions).
- Most active insider: RA CAPITAL MANAGEMENT, L.P. with 15 transactions totaling $5.4M.
- Largest single purchase: $1.4M by RA CAPITAL MANAGEMENT, L.P. on Jul 16, 2026.
- 43% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.
Activity skews bullish — buys outpace sales.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | Fred Aslan | ARTV | Award | 110,000 | — | — |
| Sep 15, 2026 | Fred Aslan | ARTV | Award | 315,000 | — | — |
| Sep 10, 2026 | Alison Moore | ARTV | Award | 16,250 | — | — |
| Sep 10, 2026 | Elizabeth L Hougen | ARTV | Award | 16,250 | — | — |
| Sep 10, 2026 | Brian Daniels | ARTV | Award | 16,250 | — | — |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=ARTV" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.
Institutional Ownership
Top 13F-HR holders of Artiva Biotherapeutics, Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →